|
Volumn 187, Issue 4, 1998, Pages 429-442
|
Pancreatic cancer: 1998 update
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRCA2 PROTEIN;
FLUOROURACIL;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
PROTEIN P16;
PROTEIN P53;
TUMOR CELL VACCINE;
BASE MISPAIRING;
CANCER ADJUVANT THERAPY;
CANCER PALLIATIVE THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONFERENCE PAPER;
DUODENUM OBSTRUCTION;
HUMAN;
IMMUNOTHERAPY;
MOLECULAR BIOLOGY;
OBSTRUCTIVE JAUNDICE;
ONCOGENE K RAS;
PANCREAS CANCER;
PANCREATICODUODENECTOMY;
PHASE 1 CLINICAL TRIAL;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR GENE;
CANCER VACCINES;
CHEMOTHERAPY, ADJUVANT;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
IMMUNOTHERAPY;
NEOPLASM STAGING;
PALLIATIVE CARE;
PANCREATIC NEOPLASMS;
PANCREATICODUODENECTOMY;
RADIOTHERAPY, ADJUVANT;
TREATMENT OUTCOME;
|
EID: 0031718349
PISSN: 10727515
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (71)
|
References (86)
|